Levobupivacaine Kabi

Levobupivacaine, the active ingredient in Levobupivacaine Kabi, is a local anesthetic presented as a sterile solution for epidural use. It provides regional nerve block for surgical anesthesia, analgesia during labor, and postoperative pain control in adult patients and can be administered by trained anesthesiologists in hospital settings.

GNH USA supplies Levobupivacaine Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Levobupivacaine is indicated for epidural anesthesia and analgesia across several clinical situations.

Epidural anesthesia: provides complete loss of sensation for surgical procedures requiring regional block. Epidural analgesia: delivers effective pain relief during labor and delivery. Surgical anesthesia: enables regional anesthesia for operations performed under epidural technique. Labor analgesia: offers controlled pain management for parturients during childbirth. Postoperative pain management: reduces pain after surgery through epidural infusion.

Adverse reactions may occur with Levobupivacaine use.

Common Side Effects: - Hypotension: reduced blood pressure after epidural administration. - Bradycardia: slower than normal heart rate. - Nausea or vomiting: gastrointestinal upset. - Dizziness or light‑headedness. - Metallic taste in the mouth. - Headache at the injection site.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Seizures: convulsive activity due to high plasma levels. - Respiratory depression: reduced breathing effort. - Allergic reaction: rash, itching, or anaphylaxis. - Prolonged motor block: extended loss of muscle function. - Nerve injury: persistent sensory deficits.

Careful assessment and monitoring are required when using Levobupivacaine.

Patient assessment: evaluate cardiovascular status before epidural administration. Dose titration: adjust the dose based on individual response and clinical effect. Concomitant CNS depressants: avoid or closely monitor when combined with other central nervous system depressants. Allergic history: confirm no hypersensitivity to amide‑type local anesthetics. Pregnancy: use only when the expected benefit outweighs potential risk to the fetus. Store at room temperature: keep in the original packaging, protect from light and moisture.

Levobupivacaine may interact with other medicines, altering safety or efficacy.

Major Interactions (Avoid): - Other local anesthetics: risk of cumulative toxicity. - Potent CYP3A4 inhibitors: may increase plasma concentrations. - Beta‑adrenergic blockers: can enhance bradycardia.

Moderate Interactions (Monitor Closely): - Sedatives or hypnotics: increased central nervous system depression. - Vasopressors: may mask hypotensive effects. - Anticoagulants: heightened risk of spinal or epidural hematoma.